Some endocrine-active compounds (EACs) act as agonists or antagonists of specific hormones and may interfere with cellular control processes that regulate gene transcription. Many mechanisms controlling gene expression are universal to organisms ranging from unicellular bacteria to more complex plants and animals. One mechanism, coordinated control of batteries of gene products, is critical in adaptation of bacteria to new environments and for development and tissue differentiation in multi-cellular organisms. To coordinately activate sets of genes, all living organisms have devised molecular modules to permit transitions, or switching, between different functional states over a small range of hormone concentration, and other modules to stabilize the new state through homeostatic interactions. Both switching and homeostasis are regulated by controlling concentrations of hormone-receptor complexes. Molecular control processes for switching and homeostasis are inherently nonlinear and often utilize autoregulatory feedback loops. Among the biological processes contributing to switching phenomena are receptor autoinduction, induction of enzymes for ligand synthesis, mRNA stabilization/activation, and receptor polymerization. This paper discusses a variety of molecular switches found in animal species, devises simple quantitative models illustrating roles of specific molecular interactions in creating switching modules, and outlines the impact of these switching processes and other feedback loops for risk assessments with EACs. Quantitative simulation modeling of these switching mechanisms made it apparent that highly nonlinear dose-response curves for hormones and EACs readily arise from interactions of several linear processes acting in concert on a common control point. These nonlinear mechanisms involve amplification of response, rather than multimeric molecular interactions as in conventional Hill relationships.
Endogenous steroid hormones interact with their respective protein receptors to regulate gene transcription, organize pleiotropic responses in specific cell types, and coordinate physiological functions at the level of the intact organism. These hormone-regulated processes can be disrupted by the presence of sufficiently high doses of endocrine active compounds (EACs) (Chapin et al., 1996; Colborn and Clement, 1992; Gray and Kelce, 1996) . A major area of controversy in risk assessments for the adverse effects associated with endocrine system disruption from these EACs is the shape of the dose-response curve for these effects at low doses of the EACs (Barton and Andersen, 1997) . Arguments have been made for linear lowdose extrapolation as done with electrophilic, DNA-reactive carcinogens, or for threshold approaches used with most noncancer risk assessment (Barton and Andersen, 1998) .
With DNA-reactive carcinogens or with chemicals that cause effects by reactivity and cytotoxicity, there is generally no pre-existing biological role for the exogenous chemical itself or for analogs of the exogenous reactive compounds in the organism. In contrast, EACs alter the normal function of hormones, which themselves have tightly regulated dose-response behaviors. In essence, EACs lead to perturbations of the dose-response behavior of natural hormone ligands. These perturbations, when sufficiently large, can lead to adverse biological responses during developmental stages or in the adult stage. Thus, low-dose-risk assessment extrapolations with EACs require two distinct steps, i.e., an understanding of the overall dose-response of the natural ligand in eliciting biological responses and then an understanding of the impact of small perturbations caused by the EACs.
Endocrine-active compounds can disrupt biological processes by virtue of several different modes of action. They may alter synthesis or clearance of endogenous hormones, affect function of specific endocrine tissues, or may act as agonists or antagonists of normal hormones. The lipophilic hormones synthesized by endocrine organs interact with cellular protein receptors to form hormone receptor (H-R) complexes (Katzenellenbogen et al., 1996) . Hormone-bound receptors bind to genes via specific DNA sites and accessory proteins; referred to here as hormone receptor receptors (HRRs) (Katzenellenbogen et al., 1996; Stancel et al., 1995; Shibata et al.,1997) . Binding to the HRRs located throughout the genome can alter transcription of single genes or groups of genes (Landers and Spelsberg, 1992) . These changes in gene transcription may modulate concentrations of constituitively expressed genes or may lead to synthesis of otherwise unexpressed gene products in the cells (Shapiro et al., 1989; Yamamoto, 1985) . In some cases, the coordinated control of sets of gene products by the HRR complex leads to a more extensive change in characteristics of the cell itself, producing differentiation or reversibly altering phenotypic characteristics that persist until hormone concentrations fall to lower concentrations (Shapiro et al., 1989) .
While a great deal has been uncovered regarding the specific protein factors involved in regulation of gene expression by H-R complexes, less information is available about the coordinated processes by which these complexes regulate batteries of genes and by which they control cellular characteristics in a broad sense (Landers and Spelsberg, 1992; Yamamoto, 1985) . The events associated with receptor-hormone control of individual genes have frequently been represented as a linear sequence of steps ( Fig. 1) (Clark and Mani, 1994) . This schematic fails to capture the dynamic interactive processes involved in biological regulation of receptor function in vivo that are essential in creating the normal, interactive dose-response for the native ligands. These interactive control processes can occur through the interaction of different tissues, such as in the gonadal-hypothalamic axis, or inside individual cells, for example, through receptor autoregulation by the R-H complex.
In most control systems there are two types of feedback processes that act to regulate system behavior-they are termed positive and negative feedback. In the endocrine system both types of feedback occur. An example is in the cyclical control of menstrual cycles in humans or of estrus cycles in spontaneously ovulating laboratory species (Freeman, 1994; Hotchkiss and Knobil, 1994) . Estrogen has a negative feedback effect on the release of FSH from the pituitary, which controls ovarian estrogen production. However, after tissue exposures to estrogen at higher levels for a period of time, the pituitary is primed for a positive feedback mediated LH surge to initiate ovulation (Fig. 2) .
We refer to aspects of these two general types of feedback control as switching (i.e., a form of positive feedback) and modulation (i.e., a form of negative feedback). Switching in this context does not simply refer to a process with two states, either on or off. Instead, it conveys the dynamic concept that this change of state occurs in response to relatively small alterations in the concentration of the active ligand molecule, i.e., the hormone or EAC. Qualitative changes in cell behaviors, with only a small change in ligand or xenobiotic concentration, will lead to highly nonlinear responses, as noted with regional induction of metabolizing enzymes in the liver by various xenobiotics (Andersen et al., 1997b) . This report explores some cellular strategies used by various organisms to achieve hormonally-mediated switching between different cellular states and evaluates the impact of positive feedback 
FIG. 2.
Feedback processes for controlling estradiol concentrations during the rat estrus cycle. LH: luteinizing hormone, FSH: follicle stimulating hormone, GnRH: gonadotropin releasing hormone, (ϩ) positive feedback process, (Ϫ) negative feedback process.
control processes on dose-response curves for hormone-receptor complexes. Mechanisms of switching are discussed by reference to published literature and by development of instructive, quantitative simulation models that illustrate these various concepts based on regulation of concentrations of active hormone-receptor complex. The presence of switches for concerted transcriptional control of batteries of genes has important consequences for the expected dose-response curves, for responses to EACs in the low-dose region.
METHODS/RESULTS

Model Development
The conceptual basis for constructing simulation models for the regulation of sets of gene products can be traced back to early observations in bacteria (Lehninger et al., 1993) . The operon concept, developed in different bacterial systems, relates to the simultaneous control of a set of genes required for regulating a specific physiological process. Several molecular mechanisms have been unraveled that are involved in achieving control of transcription of these operons. First, the genes are usually contiguous-a single promoter region controls the expression of all the genes needed for the anabolic or catabolic processes being controlled by the operon. In the lactose operon of E. coli, the proteins controlled were those necessary for utilization of lactose as an energy source. Transcription of the set of genes is regulated by a repressor protein. The tetrameric lac-repressor binds to the promoter in the absence of ligand (the equivalent of a hormone) and blocks transcription of the genes in the operon. The first enzyme in the operon, ␤-galactosidase, converts lactose to allolactose, which binds the repressor, leading to its dissociation from the promoter region of the operon and to expression of all the genes in the operon. Two salient characteristics in this control system are the polymerization of the repressor protein and the activation of a converting enzyme to synthesize the high affinity ligand for the repressor.
Another extensively studied bacterial operon is involved in light production by the marine bacteria Vibrio fischeri, now called Photobacterium fischeri (Shadel and Baldwin, 1991; Losick and Kaiser, 1997) . This organism is found in the lightemitting organs of squid and fish. In a free-living state, there is little expression of the genes required for bio-luminescence. These organisms have to reach a critical density within the light emitting organs to initiate light production. This conversion to a bioluminescent state is controlled by a transcriptional activator, the LuxR protein, and a small-molecule cell-density signal, N-(3-oxo-hexanoyl)homoserine lactone, that can bind to the LuxR protein. The lactone diffuses out of the cell and serves as a cell-density signal in a colony of free-living bacteria. The Lux genes are arranged into two operons that are divergently transcribed from a common regulatory region: the LuxR gene and the remaining 6 genes required for bioluminescence. The first gene in this latter reading frame codes for the enzyme responsible for biosynthesis of the lactone from normal products of cellular metabolism. In this bacterial system, two separate strategies are involved in switching the operon from an inactive to an active configuration, over a relatively small increase in lactone concentration. The two strategies are receptor autoinduction and signal enhancement through induction of enzyme to convert substrate to active ligand. The consequences of these processes for producing switching from a basal state to a bioluminescent condition can be illustrated by development of simple quantitative simulation models for these processes. These simulation models are generic and could describe bacterial or eukaryotic switching processes, as noted later.
Models Based on Receptor Autoregulation
A simple model for transcriptional control was devised that included H-R complex formation, receptor dimerization, receptor autoinduction, induction of an enzyme that converted a lower affinity ligand (Hi) to a ligand with higher affinity for the receptor (Hj), and expression of a hormone-dependent reporter gene. The process control strategies are similar to those just described for bacteria and are also representative of processes in mammals (Fig. 3) .
Receptor autoinduction was controlled by an increase in transcriptional activity above the basal level of synthesis, pro0. The rate of change in the receptor protein concentration is:
Induction is related to promax, the maximum rate of synthesis given in multiples of the basal rate and HRR occupancy, occup. The degradation rate constant for the receptor is kreceptor. The constants used in these exercises were arbitrary. The parameters were assigned values so as to have full occupancy of the HRR sites by the H-R complex under basal conditions, in the absence of autoregulatory interactions.
The proportionate occupancy of the HRR by the receptor ligand dimer in Equation 1 is occup. If the receptor protein is designated R, the amount of dimer is the sum of the dimers with either Hi or Hj as ligands.
The proportionate occupancy is:
Here, Kdna is the dissociation constant for the dimer-HRR binding site. In this simplified model structure, the concentra-tion of DNA-binding sites is assumed to be small, so the binding of liganded dimer to the DNA sites does not significantly alter the free concentration of liganded dimer. In addition, the binding of the ligand to the receptor protein does not reduce the free concentrations of ligand to any appreciable extent. This receptor-ligand dimer also regulates a reporter gene product, protein2. The mass balance equation for protein2 is similar to the equation for the receptor protein above (i.e., Equation 1). The shapes of the induction curve for protein2 vary considerably, depending on the extent of receptor autoinduction (Fig.  4) . The curves here show the ligand-concentration dependence of the induction of the reporter protein for promax values of 0.0, 1.0, 2.0, 5.0, and 10.0 (i.e., up to a 10-fold induction in receptor concentration). The model was run for various ligandinput rates. The x-axis in these plots is the concentration of the inducing ligand, Hi (only low affinity hormone was present in these simulations). The y-axis is the concentration of the reporter protein, protein2.
As promax increases, the curves for induction of the reporter gene become steeper and the relationship between protein2 expression and ligand concentration becomes highly nonlinear. The degree of nonlinearity for these curves was evaluated by fitting a Hill equation [response ϭ response(max) ‫ء‬ dose n / K n ϩdose n )] to the simulated data. The fit provided estimates of a steepness parameter, n, and the apparent affinity parameter, K. For the five curves with induction levels of 0, 1, 2, 5, and 10, the Hill coefficients were 1.7, 2.3, 2.9, 6, and 12, respectively. The estimated K values fall, with increasing autoinduction. K values for these curves were, respectively, 0.16, 0.11, 0.08, 0.045, and 0.025. It should be stressed that these nonlinear relationships are observed, even though the individual processes in equation (1) and the equivalent equation for the reporter gene are described with simple Michaelis-Menten binding isotherms. Receptor autoinduction leading to increasing steady-state receptor concentrations produce switching over a relatively narrow range of ligand concentration, leading to highly nonlinear dose-response behaviors.
Production of High-Affinity Ligands
The model input for low-affinity ligand, Hi, has a zero-order rate-input rate, lpro. This is equivalent to a constant rate of synthesis or rate of ingestion of the hormone or EAC. The ligand is eliminated from the central compartment by metabolism with a first-order rate constant, kl, or is converted to a high-affinity ligand, Hj, with a first-order rate constant that is some multiple of the elimination-rate constant. The relative rate of metabolism to Hj is determined by the maximal rate, metind, and the proportionate occupancy of the promoter regulating transcription of the Hi f Hj-converting enzyme. In this instance, the occupancy of the HRR leads to proportionate increases in the concentration of a converting enzyme. Thus, the rate of the interconversion reaction is then assumed to be related to the concentration of this converting enzyme.
The high-affinity ligand, Hj, is derived from the metabolism of Hi and it is lost with the same degradation rate constant (kl) as used for the low affinity ligand.
These simulations assumed that the efficacy of liganded dimer for activating transcription is independent of whether the ligand is Hi or Hj (i.e., Hi and Hj are full agonists producing equivalent maximal response at high ligand concentrations relative to their Kd's).
The following simulations were conducted assuming that the dissociation constant for Hi (Kdi) was 10 times higher than the dissociation constant for Hj (Kdhj). The parameter, metind, is the maximal rate of conversion to Hj in multiples of kl, the Figure 4 with receptor autoinduction, induction of the conversion of low-to high-affinity ligand (i.e., increasing metind) increases the steepness of the reporter protein expression curves.
When both receptor autoinduction and induction of the converting enzyme occur together, a much steeper induction of the reporter protein is achieved (Fig. 6 ). These curves are for promax and metind combinations of 0.0/0.0, 1.0/0.25, 2.0/0.5, and 5.0/1.0. Note that the x-axis in Figures 5 and 6 is total ligand concentration-the sum of the concentrations of both Hi and Hj. Once again the steepness is achieved from two linear processes that combine to increase both receptor number and receptor occupancy for specific ligand concentrations. While both these processes are linear at the level of the genomic interactions, they control steps that amplify their action by increasing the receptor number and catalyzing production of more active ligands at any given ligand input rate, lpro.
Hysteresis
The positive-feedback interactions that produce switching behaviors in these simplified biological simulation models also lead to a phenomenon called hysteresis. Hysteresis is observed by the difference in the relationship between a response and an input variable, depending on whether the response is elicited by an upward-or a downward-moving perturbation of the variable. To examine hysteresis, the reporter gene simulation model was altered to run a situation in which the ligand concentration increases exponentially toward a plateau (1Ϫe Ϫkt ) for a period of 50 h and then falls exponentially (e Ϫkt ) until the termination of the simulation at 100 h. The rate constant for both the accumulation and the elimination of ligand had the same value, ka ϭ 0.1. Although the simulations are run against time as the independent variable, the plots are constructed for the concentration of reporter gene as a function of the total concentration of active ligand in the system (Hi and Hj).
Two cases were simulated to assess the possible influence of hysteresis. The first situation was one in which there was neither receptor autoinduction nor induction of the ligandconverting enzyme. The input rate for this simulation was 1.0. This value was chosen by inspecting Figure 4 . An input value of 1.0 will increase the reporter gene by nearly 9.0-fold. The second condition had both receptor autoinduction (promax ϭ 10.0) and induction of the converting enzyme (metind ϭ 0.5). For the second condition, the value of lpro was 0.10 (see Figs. 4 and 5). This value for ligand input caused ϳ95% increase in reporter gene concentrations in the simulations with combined effects of autoinduction and increased converting-enzyme activity. The two hysteresis curves (Figs. 7A and 7B) have much different shapes. In both of these figures, the lower curve shows the relationship of reporter gene concentration and ligand concentration during the exponential increase in ligand concentration in the compartment. The upper curve is for the period of time when the compartmental concentration is falling back toward zero. The upward-and downward-going portions of the curve at the high-concentration, non-inducing situation depart slightly from each (Fig. 7A) . The upward-and downward-moving curves for the auto-induced situation are decidedly different (Fig. 7B) . The lower-concentration, high-induction curve has distinct stable regions where there is little change in reporter gene concentration over fairly large changes in ligand concentration. These stable regions differ for the upward-and the downward-moving regions of concentration. The presence of these two stable regions gives rise to the hysteresis. In the upward-going portion of the curve, ligand is not easily able to cause induction because the receptor concentration is low initially and has to be auto-induced. In the downward portion of the curve, receptor concentrations are fully induced and ligand concentrations have to fall to much lower levels to reduce the receptor-hormone complex to levels that are no longer inducing. Hysteresis likely plays a role in stabilizing cellular differentiation induced by exposure to active ligands. Hysteresis is also a hallmark of nonlinear control processes regulating the hormone-receptor complex and, in control parlance, stabilizes the switch in its new state.
Receptor down-regulation, another common regulatory strategy, is a mechanism by which a cell or organism could avoid hysteresis or state-locking, after induction. By linking the switch to receptor down-regulation, the upward-and downward-going portions of the response curves would be more closely matched.
DISCUSSION
The simple models developed above provide conceptual simulations of receptor-hormone autoregulation of the concentration of the receptor-hormone complex. Receptor autoregulation is a natural process in regulatory control mechanisms and is a central feature of the equations for receptor autoinduction and for induction of the converting enzymes (equations 1, 4, and 5). Another regulatory component occurs at higher receptor-hormone complex concentrations where hormone-receptor complex concentrations can down-regulate receptor concentration. This behavior has been seen and well characterized in the LuxR operon from Photobacterium fischerii and in the mammalian sex steroid receptors (Clark and Mani, 1994) . Receptor-hormone complex autoregulation occurs because this complex is the active controlling moiety involved in transcriptional control. In many cases its transcriptional control properties extend to the regulation of concentrations of both the receptor and the ligand. The contrasts between linear processes initiated by a receptor-hormone complex and nonlinear control strategies are shown in Figure 8 . The regions marked with (o), (ϩ), and (-) represent regions of these curves dominated by linear processes, by positive feedback, and by negative-feedback processes, respectively. These figures capture the difference between a static linear representation of receptor-hormone interaction ( Fig. 8A and Fig. 1 ) and dynamic, nonlinear interactions ( Fig. 8B and Fig. 3 ). These nonlinear, autoregulatory control processes have been noted and evaluated in a variety of bacterial and eukaryotic species. 
Bacterial Transcriptional Control
Nonlinear switching mechanisms are characteristic of the strategies used to control the cellular concentrations of gene products in all living organisms. In bacteria, the transcriptional control occurs due to the binding of regulatory proteins, many of which have a helix-turn-helix DNA binding motif (Pabo and Sauer, 1992) . Small molecules bind these proteins, either relieving repression or producing a liganded-regulatory protein complex that binds a promoter region and initiates transcription. These strategies occur with the lac operon in E. coli and the Lux operons in V. fischeri. Many bacteria utilize homoserine lactones as signaling molecules to regulate discrete metabolic sequences and to mediate growth in response to changes in colony density (Salmond et al., 1995) . It is becoming increasingly apparent that these signaling mechanisms in bacteria represent a means for regulating the behavior of larger populations of single-cell organisms by the transfer of chemical signals among individuals in the population.
A recent example demonstrated the formation of bacterial biofilms by Pseudomonas aeruginosa (Davies et al., 1998) . At a sufficiently high density, these bacteria use an acyl-homoserine lactone as the signaling molecule to organize formation of biofilms, consisting of multicellular pillars and columns with associated water channels through which nutrients can flow to cells and from which waste products can be eliminated. These spaces function as a primitive circulatory system for these organized bacterial colonies. These biofilms are of medical importance, since once formed in catheters, they are relatively resistant to antibiotic treatment.
Nonlinear Transcriptional Control in Eukaryotes
The coordinated control of multiple genes by a single HR complex is more complex in eukaryotes due to the organization of genetic material into a set of chromosomes. In the eukaryote genome, coordinately induced genes tend to be widely distributed on multiple chromosomes. This arrangement presents difficulties for coordinate control by a common H-R complex. In contrast to the situation with a single promoter for a bacterial operon, the promoter sites for distributed genes spread on multiple chromosomes would compete for available H-R complexes. Despite a situation consistent with competition among many binding sites, these eukaryote hormonally-controlled gene batteries may also respond in concert over a narrow range of hormone concentration. In eukaryotes, receptor-autoinduction appears to be a fairly common strategy for transcriptional control (Tata et al., 1993) . Several examples of autoinduction have been characterized and are involved in control of physiological processes that can be disrupted by EACs. Nonlinear, auto-regulatory control processes are expected to have important roles in development and maturation. A partial list of receptor auto-regulated processes in eukaryotes includes:
(1) In Drosophila, ecdysone acts as a temporal signal to coordinate tissue-specific morphogenetic changes during metamorphosis. Ecdysone has been shown to up-regulate ecdysone receptor transcripts (Andres and Thummel, 1992; Karim and Thummel, 1992) . The ecdysone receptor is a member of the steroid hormone-receptor superfamily of transcriptional activators.
(2) All isoforms of the mouse retinoic acid receptor (RAR) are induced by retinoic acid (Lehmann et al., 1992) . There is a retinoic acid response element (RARE) in the promoter region of the RAR-␤ gene (de The et al., 1990; Sucov et al., 1990) whose expression is strongly enhanced in a tissue and isoformspecific manner during embryonic development in mammals.
(3) Auto-up-regulation of Xenopus estrogen receptor (Shapiro et al., 1989) and thyroxine receptor (Tata et al., 1993) occur during vitellogenesis in males and in metamorphosis. The regulation of these receptors has been particularly well characterized. Some questions have been raised about the relevance of observations with the Xenopus estrogen receptor for predicting estrogenic responses in other species. The regulatory characteristics of mammalian estrogen receptors, especially in relation to auto-up-regulation, have not been as closely examined as in the amphibian species.
(4) Up-regulation of androgen receptors and androgen-receptor message have been noted in several tissues, including smooth muscle cells from rat penis (Gonzales-Cadavid et al., 1993) , human bone cells (Wiren et al., 1997) , and prostate (Mora et al., 1996) . In addition, the enzyme 5-␣-hydroxytestosterone reductase, which converts testosterone to dihydrotestosterone (DHT), is up-regulated by DHT via the androgen receptor (George et al., 1991; Russell and Wilson, 1994) .
(5) Induction of cytochrome P450 isoenzymes in the liver by transcriptional activation has been linked to increases in specific nuclear receptors. Dioxin induction of CYP 1A family enzymes occurs via a dioxin-arylhydrocarbon (Ah) receptor complex, acting as a transcriptional regulator of these proteins. Ah receptor levels increase in the liver following dioxin treatment (Sloop and Lucier, 1987 ). The precise mechanism of this regulation is not known. Peroxisomal proliferators cause induction of CYP 4A family isoforms through transcriptional control exerted by the peroxisomal proliferator-activating receptor (PPAR) (Krey et al ., 1997) . This receptor is a member of the steroid hormone-receptor superfamily and functions by heterodimer formation with retinoic acid receptors (RAR). Along with CYP 4A induction, there is also an increase in PPAR when rats are dosed with fenofibrate (Gebel et al., 1992) . CYP family induction in liver by a wide range of substrates may be associated with receptor autoinduction by bioactive ligand molecules.
(6) An all-or-none switch appears to be involved in sex determination in many species of egg-laying reptiles (Crews et al. 1994) . Temperature acts on genes encoding hormone receptors and steroid-synthesizing enzymes. In one hypothesis, there is competition by estradiol-or dihydrotestosterone-forming enzymes for testosterone, a precursor common to both metabolites (Crews et al., 1994) . Either estradiol or dihydrotestosterone can participate in a positive feedback loop, increasing the enzyme responsible for its synthesis. Depending on temperature, one or the other feedback loop fires first leading to a large burst of active steroid. Because of the common precursor (testosterone), once a feedback loop is initiated, the formation of the other sex steroid is reduced, locking the direction of subsequent development. This example appears to work more on a principle of H-R complex control of the enzyme involved in generating a more potent ligand. Receptor autoregulation may also occur, although it has not yet been demonstrated unequivocally.
These examples all involved upregulation of DNA-binding receptor proteins and/or rate limiting enzymes for ligand (hormone) synthesis. However, the characteristics of switching may also occur through very different cellular mechanisms, as has been demonstrated in the next example from the field of iron regulation.
Nonlinear Translational Control
Nonlinear control processes in iron homeostasis occur at the level of mRNA translation, through multiple interactions in concert, to determine whether iron will be mobilized to different tissues or stored intracellularly in ferritin (O'Halloran, 1993) . Iron disposition is regulated by (1) production of cell surface transferrin receptors that internalize iron complexed to plasma transferrin and (2) production of ferritin, a cellular storage protein for iron. Concentrations of these two proteins are controlled by a mRNA-binding protein, the iron response element-binding protein (IRE-BP) (Leibold and Munro, 1988) . This regulatory protein has four iron-binding sites. At low iron concentrations when less than four sites are occupied, the IRE-BP binds sites on the mRNAs for both the transferrin receptor and ferritin (Barton et al., 1990) . This stabilizes transferrin mRNA, leading to higher productions of transferrin and suppressing ferritin mRNA translation. As the concentration of iron increases, all four sites on the IRE-BP bind iron, resulting in a change in conformation. The fully liganded IRE-BP dissociates from the mRNAs leading to degradation of transferrin mRNA and activation of translation of ferritin mRNA. In addition, the fully liganded IRE-BP now has enzymatic activity-it is the cytosolic form of aconitase, the enzyme that converts citrate to isocitrate. Citrate has a higher affinity for iron than does isocitrate. The activation of aconitase and conversion to a lower affinity ligand would increase the concentration of free iron even further. This example also shows the interaction of multiple mechanisms-multimeric ligand-receptor interactions of iron with the IRE-BP, coordinate control of different cellular responses that have opposing effects on iron disposition, and regulation of free cellular iron concentrations. The activation of aconitase should introduce some degree of hysteresis, stabilizing the iron storage state in the face of downward-moving concentrations of iron.
Risk Assessment Implications
Low-dose risk extrapolations for receptor-mediated processes have been the subject of extensive discussion in recent years. This area burst into the consciousness of the toxicology profession with the reassessment of the carcinogenic risks posed by exposure to dioxin (EPA, 1997). Receptor-mediated processes had been investigated by the pharmaceutical industry with respect to the efficacy and action of wide variety of drugs. Over time, quantitative theories of drug-receptor interactions were developed. This discipline was more interested in insuring efficacy in the majority of exposed individuals (patients) than in insuring the lack of response in all but a small portion of a population (1 per 1,000,000 or 1 per 10,000 healthy individuals). These different points of view, one emphasizing efficacy and the other emphasizing safety, provide much different perspectives on our ability to confidently evaluate the shape of the dose-response curve at low doses. Pharmacologists are satisfied with the assertion that, below a certain dose, there is a complete absence of response. Toxicologists and risk assessors, however, need to understand the biological foundation for such an assertion, if indeed it is true. The history of the study of receptor-ligand interactions provides some light on the issues of behavior in the low-dose region.
In a simple scheme for receptor-hormone interaction, the initial steps relate to the interaction of the hormone with the receptor (Segel, 1976; Barlow, 1980) . This step is frequently described with a Michaelis-Menten binding isotherm:
The limiting behavior occurs at low doses where the free hormone concentration is much lower than the dissociation constant. In this region (Hf),
The derivative of this function d (bound)/d (Hf) is a constant with slope Bmax/Kd. This behavior leads to a so-called linear relationship between fraction bound and hormone concentration. It is linear, since the slope factor from this derivative is independent of the dose or concentration of the ligand.
Empirically, it has been noted that some responses increase more rapidly with concentration or dose than would be expected from this simple relationship. They are frequently described with a modified binding relationship called the Hill equation that includes concentration raised to some power (Segel, 1976) .
The limiting behavior at low hormone concentration here is:
Bound ϭ Bmax ϫ Hf n /Kd n The derivative of this equation with respect to hormone concentration is: n ϫ Bmax ϫ Hf nϪ1 /Kd n . Here, the relationship between the change in bound fraction with change in hormone concentration is decidedly nonlinear in the low-dose region, increasing as some power of the free hormone concentration.
Steep nonlinear relationships then can be described by Hill equations with n values greater than 1.0, but do these Hill equations have a clearly defined biological basis? The answer is-sometimes they do, while at other times they do not. Some biological reality exists for the case of ligand interactions with polymeric proteins. For instance, hemoglobin consists of a tetramer. This polymeric protein shows cooperativity in binding oxygen where subsequent ligands bind more avidly than the first ligand. This ligand dependent change in affinity of subsequent binding gives rise to Hill coefficients greater than 1.0.
One description of the interactions of oxygen with hemoglobin is an (nϩ1)-body interaction with binding of 4 moles of O 2 to the hemoglobin tetramer with equal binding affinity at each site (Segel, 1976 Taking the logarithm and rearranging provides a linearized relationship with a slope of n.
Log [(Hb-bound)/(Hb-free)] ϭ n ϫ log (O 2 -free) Ϫ log Kd4
Thus, a plot of the logarithm of the ratio of bound to free hemoglobin, a value determined by spectrophotometric analysis, versus the logarithm of the free ligand concentration provides an estimate of the n-value, or Hill coefficient, for the interaction. However, this analysis has certain caveats. The slope usually has to be taken near the half-saturation point, since the relationship usually does not work well at low or high values of ligand saturation. The failure to accurately represent the reaction at these extremes is due to the fact that the interaction does not really proceed as a (n ϩ 1)-body reaction. Instead, it proceeds one ligand molecule at a time, with alterations in the binding constants for addition of each subsequent ligand to the polymer. In this way, the Hill equation for concerted binding is seen as a convenience to collapse a more complex series of individual steps into a single protein-ligand interaction step. Hill plots frequently show that the low dose region is still a linear representation of the interactions of ligand with the first binding site on the polymer. In another approach, where toxicological endpoints are plotted against dose or concentration and fitted to a Hill plot, an n value of greater than 1.0 simply indicates that the relationship is nonlinear (Barlow, 1980) . These relationships, however, do not convey any mechanistic information about interactions with polymeric proteins or any other specific mechanisms for the effects. Because of their empirical basis, these plots are mute about the dose-response behavior in the low-dose region.
In contrast, the plots derived in Fig. 4 -6 are nonlinear (i.e., they would have Hill plots of greater than 1.0 and for some cases very much greater than 1.0), due to specific biological interactions. The interactions may include receptor polymerization, but they are much more markedly affected by signal amplification, due to receptor autoinduction and up-regulation of enzymes for producing high-affinity binding ligands. These nonlinear interactions have a biological basis in hormonereceptor complex autoregulation and are expected to be nonlinear at all doses. As noted earlier, these autoregulatory interactions are achieved with individual interactions that are themselves linear with respect to ligand-hormone concentrations.
Another highly nonlinear response has been reported in maturation of Xenopus oocytes (Ferrell and Machleder, 1998) . In this example, progesterone induced maturation is coordi-nated via the mitogen-activated protein kinase (MAPK). The effective Hill-coefficient on the basis of individual oocytes was very high, greater than 35! The high degree of nonlinearity is associated with a positive feedback loop embedded in the control circuitry.
Hepatic Protein Induction
Induction in the liver with dioxin and the PPAR ligands appears to involve up-regulation of transcriptional regulatory proteins, the Ah and PPAR receptors, respectively. Induction of the CYP family enzymes in the liver is regional Bell et al., 1991; Tritscher et al., 1992) . At lower doses, cells are induced in the centrilobular region, and the area of induction moves outward toward the periportal region with increasing dosage. The response of individual cells is virtually all-or-none. Either a cell is fully induced for expression of the cytochrome proteins or it remains at basal levels of induction (Andersen et al ., 1997a; Andersen et al., 1997b; Bars and Elcombe, 1991; Tritscher et al., 1992; ) . In addition, the induction of CYP1A family enzymes is part of a pleiotropic response in which a large number of genes are induced. The induction reported for the Ah receptor was about 7 fold (Sloop and Lucier, 1987) consistent with steep-dose-response relationships associated with receptor up-regulation (cf., Fig. 4 ). The graded response over the liver may be due to different oxygen tensions between periportal (high O 2 tensions) and centrilobular (low O 2 tensions) regions. The Ah receptor-dioxin complex binds with another helix-loop-helix protein, the Ah receptor nuclear translocator (Arnt). This protein is the same as hypoxia-inducing factor (HIF)1-␤ (Wang et al., 1995) . The interactions of the Ah receptor and Arnt over a range of O2-tensions throughout the liver could produce the regional distribution while receptor autoinduction could account for the all-or-none induction response of individual cells. Careful studies are needed to examine the co-localization of protein induction and receptor up-regulation in liver to see the extent to which they are closely linked.
From the risk assessment perspective, decisions have to be made about the perceived relationship of these nonlinear transcriptional responses to hepatic toxicity and to toxicity observed due to effects of dioxin in other organs. The hepatic responses to these inducers, including cancer and precursor neoplastic conditions, should be extremely nonlinear at low doses. Developing an ED01 for induction and application of safety factors of 10 -100 should insure safe exposure to these compounds (Andersen et al., 1997c) . Interspecies extrapolation of dioxin risks related to these hepatic effects requires knowledge of pharmacokinetics of the ligand in humans and rats and on characteristics of Ah receptor binding in the different species. Other toxic effects of the dioxin-like compounds, for instance the effects of dioxin on development, may also be associated with those concentrations under which the receptors initiate autoregulatory feedback loops. Thus, strategies for avoiding concentrations that activate the switching process in the liver may also be protective for effects in other tissues. Further studies of receptor regulation in multiple organs will be necessary to judge the feasibility of this risk assessment strategy with these compounds that induce regional enzyme induction in liver.
Vitellogenesis
Endocrine disruption has also been a concern for aquatic organisms. Exposure of fish or amphibians to estrogens can lead to vitellogenin production in males. In Xenopus, the induction of this protein requires auto-up-regulation of the hepatic estrogen receptor (ER) by exposure to estrogenic compounds. ER up-regulation is followed by up-regulation of the vitellogenin gene (Shapiro et al., 1989) . The ER induction occurs by an autoregulatory feedback loop. The upregulation of the ER in this system persists for a long time after estrogen exposure and may even be permanent (c.f. Fig. 7B ). As with the hepatic cytochrome induction, the autoregulatory feedback mechanism for vitellogenin activation supports a clear threshold in the dose region just below the observable dose range for induction.
The persistence of the ER-induction response in male Xenopus after removing the estrogenic stimulus indicates a shift in the state of the cells to a new stable phenotype. It was proposed that the low level of endogenous estradiol in male frogs is sufficient, after switching to the induced state, to maintain the new phenotype, although it is not sufficient to create the switch in the first place. This ER auto-induction model may provide a convenient experimental system for examining irreversible switches during development. In terms of the illustrative quantitative models developed here, this alteration in physiological states of the Xenopus hepatocytes occurs due to the hysteresis in the response. With the upwardgoing portion of the response curve (Fig. 4) , a concentration of 0.02 would not lead to switching. However, in the downwardmoving region, a concentration of 0.02 would not return the system to the basal state. These nonlinear switches should be useful models for assessing dose-response characteristics of cellular differentiation and various developmental responses of EACs.
In vivo, non-linear processes consistent with positive feedback loops and switches may be identified by observing large changes in receptor or receptor message concentration associated with small changes in ligand concentrations. The message for a receptor variant-TER71, a truncated estrogen receptorvaries 500-fold in the hypothalamus during the estrous cycle (Friend et al., 1997) . The mechanisms of these sensitive dependencies on E2 for these receptor variants remain unknown.
In summary, switching on gene batteries over a narrow range of hormone concentration appears to be an inherent characteristic of autoregulatory feedback loops and a critical component of coordinate control of gene batteries in all organisms. Further attention to the molecular mechanisms of switching and the biological processes controlled in this manner will provide basic insights into developmental biology and will produce more credible evaluations of low dose risks for some EAC-related effects. The simplified pharmacodynamic models developed here could be important for directing experimental design of studies of receptor-ligand switches and assessing nonlinear dose-response curves for these EACs.
